Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIT HEADS 2.0: BCAAs in the Treatment of Concussion
NCT06829498Phase 2Completed
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Branchamin in concussion (mTBI). Started Apr 2025; status: completed.
02
Drugs
Branchamin
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT06829498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06829498.